gemini-2.5-flash-preview-09-2025| input-price: 0.3 output-price: 2.5 max-context-length: 128_000 (cost: $0.010) · Anfrage: 2026-02-01T22:51:22.955830

Generated by rs-summarizer Version unbekannt

Abstract:

This material provides an in-depth analysis of cortisol's complex role in metabolic regulation, emphasizing its transition from an acute lipolytic agent to a chronic driver of visceral adiposity and insulin resistance. The central pathological mechanism described is the cortisol-insulin loop, where stress-induced glucose elevation, coupled with hyperinsulinemia, activates the 11-beta HSD enzyme within visceral adipocytes. This process leads to localized cortisol synthesis and the formation of new fat cells (pre-adipocytes), creating a self-perpetuating cycle of weight gain resistant to conventional dieting. Furthermore, chronic cortisol is shown to suppress crucial metabolic pathways: it inhibits mitochondrial biogenesis and attenuates peripheral thyroid hormone conversion (T4 to T3) by downregulating 5-deiodinase, resulting in functional hypothyroidism undetectable by standard lab assays. Finally, cortisol impairs gut barrier integrity (zonulin/occludin), driving systemic inflammation and subsequent insulin resistance. The prescriptive strategy focuses on HPA axis management via circadian rhythm synchronization, strategic macronutrient timing (avoiding morning carbohydrates and stress-carb coupling), and targeted exercise/fasting protocols.

Analysis of Cortisol’s Role in Metabolic Dysfunction and Visceral Adiposity

Summary Rating: No ratings yet
Article Rating: No ratings yet

Source